Search Results - University of Cincinnati: Founder of Co-op, Leader in Co-op

1

UC researchers seek to combat youth weight gain from bipolar medication

September 14, 2026

Cleveland.com highlighted a University of Cincinnati initiative approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.

2

Cancer Center expert urges lung cancer screenings as too few at-risk patients get tested

September 4, 2026

The University of Cincinnati Cancer Center's Robert Van Haren, MD, spoke with Local 12 about the need for more awareness and discussions around lung cancer screenings.

3

Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug

September 1, 2026

WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.

4

Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia

September 1, 2026

The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.

5

Funding expands UC research into weight gain side effects of bipolar medication

August 26, 2026

University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.

6

Imaging reveals how a tumor-fighting drug triggers cellular breakdown

August 24, 2026

Optics trade publication SPIE highlighted research led by the University of Cincinnati's Jiajie Diao, PhD, published in Biophotonics Discovery that demonstrated how super-resolution microscopy can track how a drug alters several important structures within cancer cells.

7

UC study shows lack of awareness for lung cancer screenings across country

August 21, 2026

University of Cincinnati Cancer Center researchers have published a study in the American Journal of Surgery that found only 15% of eligible American adults have discussed lung cancer screening with their doctors.This research emphasizes the need to spread awareness and better educate the public about screening through low-dose computed tomography.

8

Mistakes to avoid when shopping for a product dupe

August 13, 2026

The University of Cincinnati’s Kelly Dobos was featured in an AARP article discussing ways to determine if “dupe” cosmetic products really are comparable to the more expensive name brand.

9

Cancer Center director charts future based on collaboration, AI

August 10, 2026

David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.

10

UC team first in world to achieve complete remission of aggressive pituitary tumor through immunotherapy

May 4, 2026

Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center were the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The case of the complete remission, which had been previously published in the Neurosurgery Journal, was verified as the first in the world with a novel immunotherapy regimen detailed in a new publication in the journal Surgical Neurology International.